Annual Report

Overview

The report describes FY2009 net sales rising 22.4% to ¥278,503 million, alongside growth in key products and royalty income. It highlights the launch of Rapiacta in January 2010 and Shionogi Pharma's full-year contribution. The company also began its third five-year medium-term business plan in April 2010, emphasizing pipeline development and global growth.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2009-2010
Period: 1 April 2009 – 31 March 2010
Language: English
Pages
File size
Restatement: Disclosed

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services